Patent Assignment
Reel/Frame 059232/0514
Notice of Grant of Security Interest in Intellectual Property (Second Lien)
Recorded: 2022-02-18
Pages: 9
Assignor
COVIS PHARMA GMBH
Executed: 2022-02-18
Assignee
BARCLAYS BANK PLC, AS COLLATERAL AGENT
745 SEVENTH AVENUE, NEW YORK, NEW YORK, 10019
Covered Properties
(30)
Heat Stable Colloidal Iron Oxides Coated with Reduced Carbohydrates and Carbohydrate Derivatives
Patent:
6,599,498 →
Application:
09/521,264 →
Process for the Production of 16,17-[{Cyclohexylmethylen)Bis(Oxy)]-11,21-Dihydroxy-Pregna-1,4-Dien-3,20-Dion or Its 21-Isobutyrat by Transketalisation
Ciclesonide-Containing Sterile Aqueous Suspension
Use of the Combination of Ciclesonide and Antihistamines for the Treatment of Allergic Rhinitis
Combination Medicament
Process for preparing crystalline ciclesonide with defined particle size
Formoterol and Ciclesonide Combination
Use of Ciclesonide for the Treatment of Respiratory Diseases
Compliance monitor and method
Stabilized Pharmaceutical Product
Stable Pharmaceutical Products
Ciclesonide containing sterile aqueous suspension
Ciclesonide-Containing Sterile Aqueous Suspension
Stabilized Pharmaceutical Product
Stable Pharmaceutical Products
Combination Medicament
Use of the Combination of Ciclesonide and Antihistamines for the Treatment of Allergic Rhinitis
Stabilized Pharmaceutical Product
Stabilized Pharmaceutical Product
Pharmaceutical Aerosol Product for Administration by Oral or Nasal Inhalation
Aqueous Suspensions of Ciclesonide for Nebulisation
Methods of Reducing Risk of Preterm Birth
Patent:
9,844,558 →
Application:
15/373,262 →
Methods of Reducing Risk of Preterm Birth
Patent:
10,471,075 →
Application:
15/709,941 →
Crystalline and Amorphous Forms of 17-Alpha-Hydroxyprogesterone Caproate
Methods of Reducing Risk of Preterm Birth
Methods of Reducing Risk of Preterm Birth
Pharmaceutical Aerosol Product for Administration by Oral or Nasal Inhalation
Methods of Reducing Risk of Preterm Birth
Use of Ciclesonide for the Treatment of Respiratory Diseases
Application:
17/447,302 →
Publication:
US 2022/0241297
Metered Dose Inhaler
Patent:
582,544 →
Application:
29/283,277 →
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Change of Name
Sep 4, 2007
From: ALTANA PHARMA AG
To: NYCOMED GMBH
Reel/Frame 019783/0625 →
Change of Name
Mar 26, 2013
From: NYCOMED GMBH
To: TAKEDA GMBH
Reel/Frame 030091/0737 →
Security Interest
Nov 12, 2014
From: AMAG PHARMACEUTICALS, INC.
To: JEFFERIES FINANCE LLC
Reel/Frame 034156/0214 →
Merger
Jul 28, 2015
From: TAKEDA GMBH
To: NYCOMED ASSET MANAGEMENT GMBH
Reel/Frame 036193/0178 →
Merger
Jul 28, 2015
From: NYCOMED ASSET MANAGEMENT GMBH
To: NYCOMED GERMANY HOLDING GMBH
Reel/Frame 036201/0261 →
Merger
Jul 28, 2015
From: TAKEDA GMBH
To: NYCOMED ASSET MANAGEMENT GMBH
Reel/Frame 036193/0224 →
Merger
Jul 28, 2015
From: NYCOMED ASSET MANAGEMENT GMBH
To: NYCOMED GERMANY HOLDING GMBH
Reel/Frame 036201/0478 →
Change of Name
Jul 29, 2015
From: NYCOMED GERMANY HOLDING GMBH
To: TAKEDA GMBH
Reel/Frame 036205/0192 →
Change of Name
Jul 29, 2015
From: NYCOMED GERMANY HOLDING GMBH
To: TAKEDA GMBH
Reel/Frame 036205/0179 →
Security Interest
Sep 25, 2015
From: AMAG PHARMACEUTICALS, INC.
To: JEFFERIES FINANCE LLC
Reel/Frame 036653/0065 →
Assignment of Assignor's Interest
Jan 11, 2017
From: TAKEDA GMBH
To: ASTRAZENECA AB
Reel/Frame 041328/0362 →
Release of Security Interest
May 15, 2017
From: JEFFERIES FINANCE LLC
To: AMAG PHARMACEUTICALS, INC.
Reel/Frame 042459/0824 →
Assignment of Assignor's Interest
Dec 10, 2018
From: ASTRAZENECA AB
To: COVIS PHARMA B.V.
Reel/Frame 047761/0435 →
Security Interest
Dec 20, 2018
From: COVIS PHARMA B.V.
To: CAPITAL ONE, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 047834/0926 →
Security Interest
Mar 12, 2020
From: COVIS PHARMA B.V.
To: CAPITAL ONE, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 052095/0262 →
Release of Security Interest
Mar 17, 2020
From: CAPITAL ONE, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
To: COVIS PHARMA B.V.
Reel/Frame 052142/0961 →
Business Transfer and Contribution Agreement
Dec 16, 2020
From: COVIS PHARMA B.V.
To: COVIS PHARMA GMBH
Reel/Frame 054793/0416 →
Assignment of Assignor's Interest
Feb 12, 2021
From: AMAG PHARMACEUTICALS, INC.
To: COVIS PHARMA GMBH
Reel/Frame 055241/0517 →
Security Interest
Feb 22, 2021
From: COVIS PHARMA GMBH
To: CAPITAL ONE, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 055354/0063 →
Corrective Assignment to Correct the Correspondence Address Previously Recorded at Reel: 055241 Frame: 0517. Assignor(S) Hereby Confirms the Assignment.
Feb 23, 2021
From: AMAG PHARMACEUTICALS, INC.
To: COVIS PHARMA GMBH
Reel/Frame 055363/0746 →
Notice of Grant of Security Interest in Intellectual Property (First Lien)
Jan 4, 2022
From: COVIS PHARMA GMBH
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 058640/0787 →
Release of Security Interest
Feb 18, 2022
From: CAPITAL ONE, NATIONAL ASSOCIATION
To: COVIS PHARMA GMBH
Reel/Frame 059043/0226 →
Release of Security Interest
Feb 18, 2022
From: CAPITAL ONE, NATIONAL ASSOCIATION
To: COVIS PHARMA B.V.
Reel/Frame 059043/0239 →
Release of Security Interest
Jun 2, 2023
From: BARCLAYS BANK PLC
To: COVIS PHARMA GMBH
Reel/Frame 063841/0208 →
Release of Security Interest in Patents
Mar 17, 2025
From: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
To: COVIS PHARMA GMBH
Reel/Frame 070537/0122 →